Mr. Malvern Munjoma | Prophylaxis | Best Researcher Award

Population Solutions for Health | Zimbabwe.

Author Profile

🎓EARLY ACADEMIC PURSUITS

From his formative years, Mr. Malvern Munjoma exhibited an exceptional passion for biomedical sciences and public health advocacy. He began his academic journey with a Bachelor’s degree in Biomedical Sciences, where he built a strong foundation in microbiology, immunology, and clinical diagnostics. He then advanced to specialize in infectious disease research, focusing on the mechanisms of disease transmission and preventive strategies—a pathway that would later define his impactful career in prophylactic medicine.

💼PROFESSIONAL ENDEAVORS

Throughout his professional career, Mr. Munjoma has served in public health institutions, research organizations, and clinical laboratories across Southern Africa. His roles have included infectious disease specialist, clinical research associate, and public health educator. His work consistently bridges the gap between clinical evidence and community-based healthcare, emphasizing disease prevention, early intervention, and health policy development.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON PROPHYLAXIS

Mr. Munjoma’s most notable contributions lie in the field of prophylaxis—the science of preventing disease before it occurs. His research spans:

Pre-exposure prophylaxis (PrEP) in HIV prevention
Tuberculosis prophylaxis in high-risk populations
Vaccination efficacy and hesitancy in underserved communities
Community-based prophylactic outreach models

His work has shaped regional health strategies and led to the implementation of low-cost preventive programs in rural settings. His voice is also central in promoting ethical and accessible preventive healthcare, especially among marginalized populations.

🌍IMPACT AND INFLUENCE

Mr. Munjoma’s influence extends beyond research. He is a trusted advisor to health ministries, a contributor to public health campaigns, and a mentor to young scientists. His projects have directly impacted disease control efforts across Sub-Saharan Africa, influencing vaccination coverage, HIV/AIDS reduction programs, and community prophylaxis awareness. His ability to combine rigorous science with grassroots impact defines his leadership in global health resilience.

🏆RESEARCH GRANTS AND FUNDING

Mr. Munjoma has successfully led and contributed to projects funded by:

The Global Fund to Fight AIDS, Tuberculosis and Malaria
USAID HIV and AIDS Programs
African Academy of Sciences (AAS) Research Fellowships

🦠LEGACY AND FUTURE CONTRIBUTIONS

As a forward-thinking researcher, Mr. Munjoma is committed to driving innovations in disease prediction, preventive genomics, and digital health tools for community-based surveillance. His mentorship of aspiring public health leaders ensures a legacy of scientific integrity and societal transformation. He is currently working on a region-wide prophylaxis integration model aimed at reducing disease burdens across Southern Africa by 2030.

🌟A VISIONARY IN INFECTIOUS DISEASES

Mr. Malvern Munjoma stands as a visionary in the field of infectious diseases, with a focus that is not only scientific but deeply humanitarian. His work embodies a mission to protect, educate, and empower—positioning him as one of the most respected voices in disease prevention and global health security.

📑NOTABLE PUBLICATIONS

Acceptability and feasibility of implementing thermal ablation as a preventive cervical cancer treatment and the comparison of treatment outcome with cryotherapy in Zimbabwe

Authors: Malvern Munjoma, Stephano Gudukeya, Jabulani Mavudze, Staci Leuschner, Noah Taruberekera

Publication Year: 2024

Journal: ecancermedicalscience

A mixed-method study of feasibility and acceptability of the Dapivirine vaginal ring among adolescent girls and young women (AGYW) in selected Zimbabwean districts

Authors: Noah Taruberekera, Tsitsi B. Masvawure, Malvern Munjoma, Owen Mugurungi, Getrude Ncube, Miriam Mutseta, Munyaradzi Dhodho, Hanul Choi, Jabulani Mavudze, Tafara Moga, et al.

Publication Year: 2025

Journal: PLOS Global Public Health

Gerardo Guillen Nieto | Pandemic preparedness | Best Researcher Award

Prof Dr. Gerardo Guillen Nieto, Center for Genetic Engineering and Biotechnology, Cuba.

Dr. Gerardo Guillen Nieto is a distinguished researcher specializing in pandemic preparedness and infectious disease management. Renowned for his innovative work in vaccine development and immunology, Dr. Guillen has significantly contributed to global health initiatives, leading critical studies that have informed public health policies and improved response strategies for emerging infectious threats. His dedication to advancing medical research and his impactful publications have earned him prestigious recognitions, including the Best Researcher Award for his exemplary contributions to pandemic readiness and prevention.

Profile:

Orcid Profile

Education

Dr. Gerardo Guillen Nieto holds a B.Sc. in Chemistry (1986) and an M.Sc. in Organic Chemistry from Odessa University, Ukraine, and earned his Ph.D. in Biological Sciences from Havana University in 1995. He has been recognized as a Senior Researcher since 2001 and was appointed Full Professor at Havana University in 2018 and at the Latin American School of Medicine in 2019. His exceptional career also includes being named a Distinguished Professor-at-Large at the University of Electronic Science and Technology of China in 2018. Dr. Guillen is a respected member of both the Cuban Academy of Science (since 2012) and the World Academy of Science (since 2022), showcasing his international acclaim and contributions to the field.

Experience

Since 1998, Dr. Gerardo Guillen Nieto has held the prominent position of Director of Biomedical Research at the Center for Genetic Engineering and Biotechnology in Havana, Cuba. In this role, he has led groundbreaking research initiatives, overseeing a wide range of projects focused on genetic engineering and biotechnological advancements that have had a substantial impact on public health and biomedical sciences both nationally and internationally.

Conclusion

In conclusion, Dr. Gerardo Guillen Nieto’s extensive career is marked by profound contributions to the fields of vaccine development and biotechnological research, showcasing a commitment to advancing global health. His leadership at the Center for Genetic Engineering and Biotechnology, along with his academic roles and membership in prestigious scientific organizations, underscore his influence in scientific innovation and education. Dr. Guillen’s impressive body of work, recognized through numerous awards and over 270 published scientific articles, highlights his dedication to combating some of the most pressing medical challenges of our time. His expertise and contributions have left an indelible mark on both the scientific community and public health initiatives worldwide.

Top Note Publications

Title: Carcinogenic Effect of Human Tumors-Derived Cell Free-Filtrates in Nude Mice

Authors: Gerardo Guillen et al.
Journal: Preprint
Year: 2023

Title: The effects of Phycocyanobilin on experimental arthritis involve the reduction in nociception and synovial neutrophil infiltration, inhibition of cytokine production, and modulation of the neuronal proteome

Authors: Gerardo Guillen et al.
Journal: Frontiers in Immunology
Year: 2023

Title: Intranasal HBsAg/HBcAg-Containing Vaccine Induces Neutralizing Anti-HBs Production in Hepatitis B Vaccine Non-Responders

Authors: Gerardo Guillen et al.
Journal: Vaccines
Year: 2023

Title: Endogenous Biological Drivers in Diabetic Lower Limb Wounds Recurrence: Hypothetical Reflections

Authors: Gerardo Guillen et al.
Journal: International Journal of Molecular Sciences
Year: 2023

Title: Reflections on Endogenous Biological Drivers in Diabetic Lower Limb Wounds Recurrence

Authors: Gerardo Guillen et al.
Journal: Preprint
Year: 2023